Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. [electronic resource]
Producer: 19960710Description: 42-6 p. digitalISSN:- 0361-8609
- Acute Disease
- Anemia, Refractory, with Excess of Blasts -- chemically induced
- Busulfan -- adverse effects
- Cell Transformation, Neoplastic -- drug effects
- Chlorambucil -- adverse effects
- Cohort Studies
- Disease Progression
- Drug Therapy, Combination
- Enzyme Inhibitors -- adverse effects
- Female
- Humans
- Hydroxyurea -- adverse effects
- Incidence
- Interferon-alpha -- adverse effects
- Leukemia -- chemically induced
- Leukemia, Radiation-Induced -- etiology
- Male
- Melphalan -- adverse effects
- Middle Aged
- Phlebotomy
- Phosphorus Radioisotopes -- adverse effects
- Polycythemia Vera -- drug therapy
- Preleukemia -- epidemiology
- Primary Myelofibrosis -- drug therapy
- Retrospective Studies
- Ribonucleotide Reductases -- antagonists & inhibitors
- Risk
- Thrombocythemia, Essential -- drug therapy
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.